Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021

SELL
$175.6 - $291.43 $830,412 - $1.38 Million
-4,729 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$174.98 - $272.83 $190,903 - $297,657
1,091 Added 29.99%
4,729 $827,000
Q3 2020

Nov 05, 2020

BUY
$185.27 - $238.73 $54,098 - $69,709
292 Added 8.73%
3,638 $708,000
Q2 2020

Aug 18, 2020

BUY
$153.32 - $191.72 $150,713 - $188,460
983 Added 41.6%
3,346 $598,000
Q1 2020

May 15, 2020

BUY
$124.34 - $193.76 $103,699 - $161,595
834 Added 54.55%
2,363 $381,000
Q4 2019

Jan 10, 2020

BUY
$134.81 - $177.8 $206,124 - $271,856
1,529 New
1,529 $251,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.11B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Advisors Capital Management, LLC Portfolio

Follow Advisors Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisors Capital Management, LLC with notifications on news.